Inotuzumab Ozogamicin

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
(ih-noh-TOO-zoo-mab OH-zoh-ga-MIH-sin)

This page contains brief information about inotuzumab ozogamicin and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Besponsa
FDA Approved
Yes

FDA Approval for Inotuzumab Ozogamicin

Use in Cancer

Inotuzumab ozogamicin is approved to treat:

Inotuzumab ozogamicin is also being studied in the treatment of other types of cancer.

More About Inotuzumab Ozogamicin

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

FDA Approves Inotuzumab for Adults with B-Cell Acute Lymphoblastic Leukemia

Targeted Cancer Therapies

Clinical Trials Accepting Patients

Find Clinical Trials for Inotuzumab Ozogamicin - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted: September 1, 2017